Claudia Peitzsch

Research Associate at CRTD

[Mareike Albert @MareikeAlbert]

How do epigenetic modifications contribute to #neocortex #development?
Excited about our new comprehensive pre-print on the #epigenome in human #corticogenesis. We identify a novel role of PRC2 in regulating #ECM composition. @CRTDpress

https://t.co/goMUbFkQAy

A thread below 👇

[DGfZ @Zytometrie]

Great presentations, inspiring poster session - the first day of a special meeting is over.

[Claudia Peitzsch @ClaudiaPeitzsch]

Great work just published from our PhD student @FranziskaSchwarz, @Oncoray, @NCRO, @NCT_UCC_DD. It was a pleasure to supervise and a lot of fun. Thanks to the whole team.

[Molecular Cancer Research @MCR_AACR]

Curious about how cancer cells become resistant to #radiotherapy? Read article by @ClaudiaPeitzsch and colleagues from @tudresden_de, Plasticity within Aldehyde Dehydrogenase–Positive Cells Determines #ProstateCancer. https://t.co/pXX6jMTulU
#AACR22 #Radiosensitivity

[Frontiers - Immunology @FrontImmunol]

New Research: Efficient DNA Repair Mitigates Replication Stress Resulting in Less Immunogenic Cytosolic DNA in Radioresistant Breast Cancer Stem Cells: Cancer stem cells (CSCs) are a major cause of tumor therapy failure. This is mainly… https://t.co/kJPv0dCX1J #immunology

[Claudia Peitzsch @ClaudiaPeitzsch]

Our new paper is out: Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity https://t.co/5TQ0dcPLv0
Great MD thesis work from #Inaki. Thanks! And a pleasure to supervise.

[Prostate Cell News @ProstateCell]

👨‍🔬👩‍🔬 Researchers at TU Dresden (@tudresden_de), led by Dr. @ClaudiaPeitzsch, analyzed irradiation-induced plasticity within the aldehyde dehydrogenase-positive population in #ProstateCancer.

Read it here in @MCR_AACR | 📑 https://t.co/Jj4JNiaciT

[Claudia Peitzsch @ClaudiaPeitzsch]

Cellular Plasticity: Tumorigenesis and Therapy https://t.co/Mpp5KR7rBa #mdpicancers via @Cancers_MDPI

[Claudia Peitzsch @ClaudiaPeitzsch]

Enjoyed and learned a lot at @5th_mass_cytometry_user_forum last week. Thanks to the organizer and to our Phd student @Daria for the clear presentation of our recent data how immune cells may influence the properties of prostate CTCs.

[Shevchenko Lab @LabShevchenko]

Very pleased to present updated Road Map and website for #MassSpec in #Dresden! We are 8 labs working on all aspects of bio-mass spectrometry!
Event' schedule comes shortly
Stay tuned!

https://t.co/1ug3w8URCC

@mpicbg @tudresden_de @NCT_UCC_DD @Lipotype_GmbH @fedorovaLab

[Claudia Peitzsch @ClaudiaPeitzsch]

Please do not miss the exciting talk of our PhD student @DariaKlusa tomorrow at @5th #ACTC conference in Greece about #CTC phenotypes in #ProstateCancer patients during #radiotherapy.

[Claudia Peitzsch @ClaudiaPeitzsch]

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy https://t.co/P2BNCcJA7u #Theranostics

[Claudia Peitzsch @ClaudiaPeitzsch]

Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response https://t.co/6VrarDfUci

[Claudia Peitzsch @ClaudiaPeitzsch]

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas https://t.co/UBDrCu3nYZ ##mdpicancers via @Cancers_MDPI